Raghav Sundar

Leader, Gastroesophageal Cancer Program, Medical Oncology · Yale Cancer Center and Smilow Cancer Hospital

Credentials: · · ·

History

Yale School of Medicine
Present

Pathology-Anatomic and Clinical
Yale-New Haven Hospital
2024–Present
National University Hospital, Singapore
2008–2011
National University of Singapore
2004–2008

Research

Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
Cancer Discovery · 2022 · Co-first of 24 authors · 466 citations
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Systematic review or meta-analysis · BMJ · 2022 · 426 citations
Gastric cancer
Review · The Lancet · 2025 · First of 7 authors · 309 citations

CC
Cheng Chee
12 papers
SK
Samuel Klempner
11 papers
Timothy Yap
10 papers
Kiran Turaga
8 papers
Michael Cecchini
7 papers
JB
Justin Bader
6 papers · 6 as a resident
NN
Natalie Ngoi
6 papers · 5 as a resident
Princy Gupta
6 papers
EG
Elizabeth Godfrey
5 papers · 5 as a resident
KS
Kurt Schultz
5 papers · 5 as a resident
Ardaman Shergill
4 papers
Jaffer Ajani
4 papers

Clinical trials

PRECISE CURATE.AI Pilot Clinical Trial
Principal investigator · Unknown · Phase 1, Phase 2
National University Hospital, Singapore
2020–2023
Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and Alopecia
Principal investigator · Unknown
National University Hospital, Singapore
2017–2020
Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC)
Principal investigator · Unknown · Phase 1, Phase 2
National University Hospital, Singapore
2017–2021
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Site PI · Recruiting · Phase 2, Phase 3
ECOG-ACRIN Cancer Research Group
2025–2030